Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
home:mp:break [10.21.2011] – [ added section about posting progress while on a break joyfulhome:mp:break [05.10.2014] – [To resume the MP] joyful
Line 29: Line 29:
  
  
-===== Providing updates on your progress ===== +===== Posting about your break =====
- +
-Those considering or on a break from the Marshall Protocol are encouraged to post information about their plans as part of their regular updates in their own [[home:starting:usingforum:postingprogress|progress thread]]. However, please do not promote or advocate any other treatment on our forums (see:  [[.:usingforum:forumpolicies|our forum policies]]).+
  
 +Those considering or on a break from the Marshall Protocol are encouraged to post information about their plans as part of their regular updates in their own [[home:starting:usingforum:postingprogress|progress thread]].
 <blockquote> <blockquote>
 We are very interested in following the long term outcomes for all our members, including those that choose to discontinue the MP as we feel we are able to learn more this way.  We are very interested in following the long term outcomes for all our members, including those that choose to discontinue the MP as we feel we are able to learn more this way. 
Line 43: Line 42:
  
 //**Joyful**, MarshallProtocol.com// </blockquote> //**Joyful**, MarshallProtocol.com// </blockquote>
- 
 ===== How to take a break ===== ===== How to take a break =====
  
Line 100: Line 98:
  
  
-===== Does disease become worse while on break? =====+===== Does disease become worse if on Benicar only? =====
  
-Latent bacterial forms, except maybe the kind one sees in the rapidly degenerative disease ALS, are very slow-growing. Abstinence from MP antibiotics for a few days or even weeks will not result in a significant increase in bacteria. If patients are experiencing some symptoms of immunopathology, they are killing bacteria and making progress towards recovery.+Latent bacterial forms, except maybe the kind one sees in the rapidly degenerative disease ALS, are very slow-growing. Patients taking Benicar alone (olmesartan without antibioticsare continuing to experience some level of the symptoms of immunopathology, then the intracellular bacteria are being dealt with and the patient is making progress towards recovery.
  
  
Line 108: Line 106:
  
  
-===== To resume the MP =====+===== Resuming olmesartan after a break =====
  
-MP patients who have discontinued olmesartan (Benicar) during a break from the MP may want to take olmesartan (Benicar) alone for a few days before resuming the minocycline. This will guard against any intolerable adjustment symptoms.+MP patients who have discontinued olmesartan (Benicar) during a break from the MP will want to take olmesartan (Benicar) without additional antibiotics while they determine how strong their own immune response is with the support of olmesartan's immune stimulative effects
  
-Patients taking a break from antibiotics for just a few days or so can resume the antibiotics at the previous dose. 
  
-Patients taking a break from antibiotics for longer than a few days should restart their antibiotics at a lower dose to assess symptoms as tolerable, to avoid a strong immune system reaction.+===== Resuming MP antibiotics after a break ===== 
 + 
 +Patients taking a break from antibiotics for just a few days or so usually find they can resume the antibiotics at the previous dose. However, patients taking a break from antibiotics for longer than a few days will need to restart their antibiotics at a lower dose to assess symptoms as tolerable, to avoid a strong immune system reaction.
 ===== Patients experiences ===== ===== Patients experiences =====
  
Line 122: Line 121:
  
 ===== Notes and comments ===== ===== Notes and comments =====
-EDIT+
  
  
home/mp/break.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.